Egypt taps Canadian technology for child oncology hospital:
This article was originally published in Clinica
Executive Summary
Canadian products and expertise are to be tapped to complete a major, publicly-funded, Cairo-based paediatric oncology centre, the Children's Cancer Hospital Foundation 57357. The hospital, which is expected to be able to treat 1,800 of Egypt's annual 3,000 new cases in children under the age of 15, has partnered with Toronto-based healthcare company, Comprehensive Care International (CCI), to develop its patient care system. According to CCI, whose oncology services include equipment specification and procurement, and health IT, this will involve "capacity building" to support the provision of: intensive care and bone marrow transplant units; a tumour surgery department; speciality clinics (pain, cardiology, dental and ophthalmology); diagnostics and laboratory support; and a radiotherapy department.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.